SCHEMBL4844982

SCHEMBL4844982

CCOc1ccc(C(=O)Nc2cccc(C(=O)C=C3NC(C)(C)Cc4ccc(OC)cc43)c2)cc1

nearest known ligand 0.48

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 8/20 0.48
KMT2A Q03164 5/20 0.48
MEN1 O00255 3/20 0.48
ALDH1A1 P00352 2/20 0.45
KDM4E B2RXH2 2/20 0.45
CYP1A2 P05177 1/20 0.45
RAB9A P51151 6/20 0.45
SMN1; SMN2 Q16637 4/20 0.45
LMNA P02545 2/20 0.45
TP53 P04637 2/20 0.44
PKM P14618 1/20 0.44
KCNK9 Q9NPC2 1/20 0.43
NR1H4 Q96RI1 3/20 0.43
MAPT P10636 2/20 0.42
TSHR P16473 1/20 0.42
MAPK1 P28482 1/20 0.42
NLRP3 Q96P20 1/20 0.41
PARP1 P09874 1/20 0.41
POLB P06746 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4844969 1.00 NPC1 (0.48) NPC1KMT2AMEN1ALDH1A1KDM4E
SCHEMBL4847135 0.94 NR1H4 (0.52) NPC1KMT2AMEN1ALDH1A1KDM4E
SCHEMBL4847141 0.94 NR1H4 (0.52) NPC1KMT2AMEN1ALDH1A1KDM4E
SCHEMBL4846015 0.92 NPC1 (0.44) NPC1KMT2AMEN1ALDH1A1KDM4E
SCHEMBL4846022 0.92 NPC1 (0.44) NPC1KMT2AMEN1ALDH1A1KDM4E
SCHEMBL4846599 0.92 NPC1 (0.53) NPC1KMT2AMEN1ALDH1A1KDM4E
SCHEMBL4846605 0.92 NPC1 (0.53) NPC1KMT2AMEN1ALDH1A1KDM4E
SCHEMBL4839736 0.92 RAB9A (0.51) NPC1KMT2AMEN1ALDH1A1KDM4E
SCHEMBL4839725 0.92 RAB9A (0.51) NPC1KMT2AMEN1ALDH1A1KDM4E
SCHEMBL4835246 0.91 NR1H4 (0.54) NPC1KMT2AMEN1ALDH1A1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7378428-B2 Nitrogen-containing bicyclic compounds and drugs containing the same as the active ingredient ONO PHARMACEUTICAL CO., LTD. (JP) 2008-05-27 US disclosed
US-20050222138-A1 Nitrogen-containing bicyclic compounds and drugs containing the same as the active ingredient ONO PHARMACEUTICAL CO., LTD. (JP) 2005-10-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050222138-A1 Nitrogen-containing bicyclic compounds and drugs containing the same as the active ingredient PARK7, MMP8, CDK7 NPC1 985/4885KMT2A 4642/4885MEN1 1230/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.